When will FDA consider whether to waive a requirement of this subpart?
21 C.F.R. § 1.1410
in effectEffective: 2024-07-01FDA will consider whether to waive a requirement of this subpart on our own initiative or in response to the following:
(a) A written request for a waiver for an individual entity; or
(b) A citizen petition requesting a waiver for a type of entity submitted under § 10.30 of this chapter by any person subject to the requirements of this subpart.
Source: eCFRURL: https://www.ecfr.gov/api/versioner/v1/full/2024-07-01/title-21.xmlFetched: 7/26/2026
